The persistent circulation of influenza A(H7N9) virus within poultry markets and 26 human society leads to sporadic epidemics of influenza infections. Severe pneumonia 27 and acute respiratory distress syndrome (ARDS) caused by the virus lead to high 28 morbidity and mortality rates in patients. Hyper induction of pro-inflammatory 29 cytokines, which is known as "cytokine storm", is closely related to the process of viral 30 infection. However, systemic analyses of H7N9 induced cytokine storm and its 31 relationship with disease progress need further illuminated. In our study we collected 32 75 samples from 24 clinically confirmed H7N9-infected patients at different time points 33 after hospitalization. Those samples were divided into three groups, which were mild, 34 severe and fatal groups, according to disease severity and final outcome. Human 35 cytokine antibody array was performed to demonstrate the dynamic profile of 80 36 cytokines and chemokines. By comparison among different prognosis groups and time 37 series, we provide a more comprehensive insight into the hypercytokinemia caused by 38 H7N9 influenza virus infection. Different dynamic changes of cytokines/chemokines 39 were observed in H7N9 infected patients with different severity. Further, 33 cytokines 40 or chemokines were found to be correlated with disease development and 11 of them 41 were identified as potential therapeutic targets. Immuno-modulate the cytokine levels 42 of IL-8, IL-10, BLC, MIP-3a, HGF, OPG, OPN, are supposed to be beneficial in curing H7N9 infected patients. Apart from the 44 identification of 35 independent predictors for H7N9 prognosis, we further established 45 a real-time prediction model with multi-cytokine factors for the first time based on 46 maximal relevance minimal redundancy method, and this model was proved to be 47 powerful in predicting whether the H7N9 infection was severe or fatal. It exhibited 48 promising application in prognosing the outcome of a H7N9 infected patients and thus 49 help doctors take effective treatment strategies accordingly. 50 51 Introduction 52 Since the first case of human H7N9 influenza virus infection reported in March, 53 2013 in China, the number increased to about 1564 at the end of Oct, 2017 according 54 to WHO [1]. With a high mortality rate at approximately of 40%, H7N9 virus poses 55 great threat to public health of human beings [2]. Most of the H7N9 influenza virus 56 infected people suffered from severe pneumonia and acute respiratory distress 57 syndrome, and around 63% patients were admitted to an intensive care unit (ICU), 58 about 62% patients had undergone mechanical ventilation [3].
CRP and/or PCT and/or T, and/or showed positive correlation with OI values ( Figure   145 4). Elevation of the 21 cytokines were supposed to be beneficial for the prognosis. 146 Similarly, we identified 14 cytokines whose elevation were related to more severe 147 symptoms, which are positively correlated with CRP or/and PCT or/and body 148 temperature, or/and negatively correlated with OI values (Figure 4) . 149 Surprisingly, in fatal patients, we found all 9 specific highly elevated cytokines 150 except IGFBP-1, are harmful, and 3 cytokines, specific down-regulated in fatal patient, 151 were beneficial when elevated. In the fatal group patients, MDC (0.63 and 0.70 fold to 152 that of mild and severe patient groups respectively), ENA-78 (0.39 and 0.47) and TGF- (Figure 3b) . These results suggested that the expression of MDC, ENA-156 78, TGF-β3 had been suppressed or those related pathways may not being activated which is supposed to be under control of host immune system. Furthermore, it is 167 reasonable to speculate that drugs or therapies helping for elevating these three 168 cytokines, especially MDC, ENA-78, TGF-β3, and targeting for decreasing the 8 major 169 harmful cytokines, would be benefit for survival and recovery in H7N9 infection. 359 The authors declare no conflict of interest whatsoever. 
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